Clinical Trials Directory

Trials / Completed

CompletedNCT03281460

Efficacy of In-bag Morcellation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Laparoscopic mini-invasive surgery supplanted laparotomy for many years, including hysterectomy or myomectomy (less postoperative complications compared to laparotomy) However the US Federal Drug Administration (FDA) strongly warned against the use of power morcellation in 2014 because of the risk of iatrogenic spread of malignant cells. The hypothesis is that in-bag morcellation may prevent cells dissemination. The investigator compare in this prospective randomized study two groups of patients: group A (in bag-morcellation during laparoscopic myomectomy or hysterectomy) versus group B (morcellation without any bag during laparoscopic myomectomy or hysterectomy)

Conditions

Interventions

TypeNameDescription
DEVICElaparoscopic myomectomy or hysterectomy with More-cell-Safe AMI bag morcellationlaparoscopic myomectomy or hysterectomy with More-cell-Safe AMI bag morcellation
PROCEDURElaparoscopic myomectomy or hysterectomy without any morcellation baglaparoscopic myomectomy or hysterectomy without any morcellation bag

Timeline

Start date
2018-01-25
Primary completion
2019-01-21
Completion
2019-01-21
First posted
2017-09-13
Last updated
2025-09-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03281460. Inclusion in this directory is not an endorsement.